Xoma | XOMA - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
AbbVie USD 62.97B 12M 2025-09
Agenus USD 169.66M 146.06M 2025-12
Agios Pharmaceuticals USD 1.06M 0 2022-09
Ardelyx USD 202.83M 696K 2025-12
aTyr Pharma USD 12.51M 12.11M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Curis USD 29.43M 10.69M 2024-06
Eli Lilly USD 40.87B 5.6M 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Incyte USD 30.2M 5.17M 2025-12
MacroGenics USD 70M 256K 2025-12
Novartis USD 29.59B 5.35B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Prothena USD 0 0 2024-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Xoma USD 94.38M 7.82M 2025-09